Sort   by:  
 Page size 
UnknownBEST: A Randomized Phase II Study of Vascular Endothelial Growth Factor, RAF Kinase, and Mammalian Target of Rapamycin Combination Targeted Therapy With Bevacizumab, Sorafenib, and Temsirolimus in Advanced Renal Cell Carcinoma--A Trial of the ECOG-ACRIN Cancer Research Group (E2804).
Not available
S-EPMC4500832 | biostudies-literature
UnknownNivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
Not available
S-EPMC4806782 | biostudies-literature
UnknownSurvival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
Not available
S-EPMC4811023 | biostudies-literature
UnknownB cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.
Not available
S-EPMC8245051 | biostudies-literature
UnknownSurvival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab.
Not available
S-EPMC4517051 | biostudies-literature
UnknownHoney bee queen health is unaffected by contact exposure to pesticides commonly found in beeswax.
Not available
S-EPMC8313582 | biostudies-literature
UnknownRandomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.
Not available
S-EPMC6018511 | biostudies-literature
ProteomicsDHFR2 Proteomic analysis - LC MS/MS NICB DCU
LC-MS/MS shotgun proteomic analysis looking at DHFR2 in mammalian cell lines.
ORGANISM(S): Homo sapiens (Human) 
2025-05-06 | PXD044513 | Pride
Dhfr2 Shotgun proteomics Lc-ms/ms 
UnknownSARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Not available
S-EPMC11192176 | biostudies-literature
TranscriptomicsExpression profiling of circulating miRNAs in Luminal A breast cancer
Breast cancer is a common disease with distinct tumor subtypes which can be phenotypically characterized by estrogen receptor, progesterone receptor and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression. Altered miRNA expression has been demonstrated in a var...
ORGANISM(S): Homo sapiens 
2013-04-24 | E-GEOD-46355 | biostudies-arrayexpress
Sort   by:  
 Page size